Neighbourly Pharmacy Revenue and Competitors
Estimated Revenue & Valuation
- Neighbourly Pharmacy's estimated annual revenue is currently $110.9M per year.
- Neighbourly Pharmacy's estimated revenue per employee is $283,750
Employee Data
- Neighbourly Pharmacy has 391 Employees.
- Neighbourly Pharmacy grew their employee count by 11% last year.
Neighbourly Pharmacy's People
Name | Title | Email/Phone |
---|
Neighbourly Pharmacy Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $22M | 97 | 4% | $5M | N/A |
#2 | $45.2M | 181 | 30% | N/A | N/A |
#3 | $3.2M | 28 | -36% | $700K | N/A |
#4 | $6.2M | 34 | -8% | N/A | N/A |
#5 | $101.9M | 359 | 20% | N/A | N/A |
#6 | $114.4M | 403 | 7% | N/A | N/A |
#7 | $67.4M | 270 | 0% | N/A | N/A |
#8 | $68.9M | 276 | 5% | N/A | N/A |
#9 | $28.8M | 127 | 0% | N/A | N/A |
#10 | $31.1M | 137 | 8% | N/A | N/A |
What Is Neighbourly Pharmacy?
N/A
Total Funding
391
Number of Employees
$110.9M
Revenue (est)
11%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Neighbourly Pharmacy News
2022-04-06 - Neighbourly Announces Exercise of $18 Million Over-Allotment Option in
Connection with Previously Announced Private Placement
TORONTO, April 14, 2022 /CNW/ - Neighbourly Pharmacy Inc. (TSX: NBLY) ("Neighbourly" or the "Company"), is pleased to announce that further...
2022-04-06 - TD Securities Begins Coverage on Neighbourly Pharmacy ...
Industrial Alliance Securities upgraded shares of Neighbourly Pharmacy to a buy rating and set a C$40.00 price objective for the company in a...
2022-03-22 - Neighbourly Announces Agreement to Acquire Rubicon ...
Neighbourly is Canada's largest and fastest growing network of community pharmacies. United by their patient first focus and their role as...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $88M | 391 | -1% | N/A |
#2 | $70.9M | 391 | 46% | N/A |
#3 | $88M | 391 | N/A | N/A |
#4 | $99.7M | 391 | -6% | N/A |
#5 | $119.7M | 391 | 2% | N/A |